Den samlede sikkerhedsprofil for MabThera til behandling af reumatoid arthritis stammer fra data fra kliniske forsøg og fra post- marketing observationer.
The overall safety profile of MabThera in rheumatoid arthritis is based on data from patients from clinical trials and from post-marketing surveillance.